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ABSTRACT
The purpose of this study was to conduct a comparative analysis of hospital 
costs incurred by patients undergoing Cardiovascular Surgery (CVS) and 
patients undergoing other medical procedures who received Continuous 
Renal Replacement Therapy (CRRT) in a teaching hospital. A total of 117 
patients were identified through review of medical charts for the period of 
January 1999 to August 2002. Twenty one percent of them were identified 
having CVS. Eighty-eight percent of the CVS patients admitted to the ICU for 
CRRT died compared to 67% for non-CVS patients (p=0.047). Average actual 
costs of hospitalization were $47,225 for CVS patients and $51,724 for non-
CVS patients. The mean length of stay (LOS) was 12.8 days for the CVS 
patients and 18.1 days for other patients (p=0.03). Mean LOS for patients who 
survived was 23.1 days whereas the average LOS for patients who died was 
14.5 days (p=0.06). The differences found between patients who had CVS with 
CRRT as compared to non-CVS patients with CRRT in terms of mortality and 
length of stay raise ethical as well cost effectiveness questions of the 
procedure. 
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GOALS 
• To conduct a comparative analysis of estimated hospital costs of a 
population of patients who have undergone CRRT. 
• To perform comparative analysis  between patients with 
cardiovascular surgery (CVS), patients with other surgeries and 
patients with no surgery  at  the ICU. 
INTRODUCTION
• Renal failure is recognized as a common complication of patients 
admitted to the Intensive Care Unit (ICU). 
• This study describes the clinical characteristics and examines 
hospital costs involved in the care of 117 patients undergoing 
Continuous Renal Replacement Therapy (CRRT). 
• End of Life decisions regarding the withdrawal, withholding of life 
supporting and futile care have become commonplace within the 
ICUs.
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CONCLUSION
•Based on the results of this analysis, we conclude that  
among patients undergoing CRRT, increased costs are incurred 
for patients <65 years old that undergo surgery and who do not 
expire in the hospital. 
•Being a female <65 years old is associated with leaving the 
hospital alive. 
•There is greater risk for male patients 65 years or older to 
expire.
•Patients undergoing CVS also have a greater risk of expiring in 
the hospital.
•These characteristics lend themselves more difficult cost 
benefit questions that involve ethical and economic decisions.
METHODS
• Retrospective review of clinical and cost data from patient discharged 
between 01/01/99 to 08/31/02 (3 fiscal years).
• Main inclusion criteria: Patients undergoing CRRT at the ICU for any 
diagnosis or disease. 
• Variables: Gender, age group, race/ethnicity, CVS surgery, other
surgeries, non surgical, length of stay, estimated costs, actual 
payments, profit (loss) and hospital discharge status. 
• Freidman's  cost to charge ratio of 33% was used to estimate cost.
DISCUSSION 
•Efforts to prolonging life once considered an outcome of 
healing may be viewed by some as harmful acts of prolonging 
suffering. 
•The costs of futile care for the dying are enormous. Futility can 
present challenges because of the monetary cost of such care, 
its negative effect on staff members and the burden it creates 
on the patient family and the clinicians .
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